[1] |
Krajˇcová A, Waldauf P, Anděl M, et al. Propofol infusion syndrome: a structured review of experimental studies and 153 published case reports[J]. Crit Care, 2015, 19: 398. DOI: 10.1186/s13054-015-1112-5.
|
[2] |
Sumi C, Okamoto A, Tanaka H, et al. Propofol induces a metabolic switch to glycolysis and cell death in a mitochondrial electron transport chain-dependent manner[J]. PLoS One, 2018, 13(2): e0192796. DOI: 10.1371/journal.pone.0192796.
|
[3] |
Okamoto A, Sumi C, Tanaka H, et al. HIF-1-mediated suppression of mitochondria electron transport chain function confers resistance to lidocaine-induced cell death[J]. Sci Rep, 2017, 7(1): 3816. DOI: 10.1038/s41598-017-03980-7.
|
[4] |
Hirota K. Hypoxia-inducible factor 1, a master transcription factor of cellular hypoxic gene expression[J]. J Anesth, 2002, 16(2): 150-159. DOI: 10.1007/s005400200011.
|
[5] |
Hirota K, Semenza GL. Regulation of hypoxia-inducible factor 1 by prolyl and asparaginyl hydroxylases[J]. Biochem Biophys Res Commun, 2005, 338(1): 610-616. DOI: 10.1016/j.bbrc.2005.08.193.
|
[6] |
Maxwell PH, Wiesener MS, Chang GW, et al. The tumour suppressor protein VHL targets hypoxiainducible factors for oxygen-dependent proteolysis[J]. Nature, 1999, 399(6733): 271-275. DOI: 10.1038/20459.
|
[7] |
Li H, Lu Y, Pang Y, et al. Propofol enhances the cisplatin-induced apoptosis on cervical cancer cells via EGFR/JAK2/STAT3 pathway[J]. Biomed Pharmacother, 2017, 86: 324-333. DOI: 10.1016/j.biopha.2016.12.036.
|
[8] |
Liu SQ, Zhang JL, Li ZW, et al. Propofol inhibits proliferation, migration, invasion and promotes apoptosis through down-regulating miR-374a in hepatocarcinoma cell lines[J]. Cell Physiol Biochem, 2018, 49(6): 2099-2110. DOI: 10.1159/000493814.
|
[9] |
Gao C, Ren C, Liu Z, et al. GAS5, a FoxO1-actived long noncoding RNA, promotes propofol-induced oral squamous cell carcinoma apoptosis by regulating the miR-1297-GSK3β axis[J]. Artif Cells Nanomed Biotechnol, 2019, 47(1): 3985-3993. DOI: 10.1080/21691401.2019.1670189.
|
[10] |
Shen C, Kaelin WG Jr. The VHL/HIF axis in clear cell renal carcinoma[J]. Semin Cancer Biol, 2013, 23(1): 18-25. DOI: 10.1016/j.semcancer.2012.06.001.
|
[11] |
Wohlrab C, Vissers MCM, Phillips E, et al. The association between ascorbate and the hypoxia-inducible factors in human renal cell carcinoma requires a functional von Hippel-Lindau protein[J]. Front Oncol, 2018, 8: 574. DOI: 10.3389/fonc.2018.00574.
|
[12] |
Aragonés J, Schneider M, Van Geyte K, et al. Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism[J]. Nat Genet, 2008, 40(2): 170-180. DOI: 10.1038/ng.2007.62.
|
[13] |
Semba H, Takeda N, Isagawa T, et al. HIF-1α-PDK1 axis-induced active glycolysis plays an essential role in macrophage migratory capacity[J]. Nat Commun, 2016, 7: 11635. DOI: 10.1038/ncomms11635.
|
[14] |
Nobes CD, Brown GC, Olive PN, et al. Non-ohmic proton conductance of the mitochondrial inner membrane in hepatocytes[J]. J Biol Chem, 1990, 265(22): 12903-12909.
|
[15] |
Chen N, Qian J, Chen J, et al. Phase 2 studies of oral hypoxiainducible factor prolyl hydroxylase inhibitor FG4592 for treatment of anemia in China[J]. Nephrol Dial Transplant, 2017, 32(8): 13731386. DOI: 10.1093/ndt/gfx011.
|
[16] |
Martin ER, Smith MT, Maroni BJ, et al. Clinical trial of vadadustat in patients with anemia secondary to stage 3 or 4 chronic kidney disease[J]. Am J Nephrol, 2017, 45(5): 380388. DOI: 10.1159/000464476.
|